Cargando…
418. Fosfomycin Dosing Regimens for The Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Receiving Continuous Renal Replacement Therapy: a Monte Carlo Simulation
BACKGROUND: To predict the appropriate dosing of intravenous fosfomycin for treatment of carbapenem-resistant Enterobacteriaceae (CRE) infection in continuous renal replacement therapy (CRRT) patients. METHODS: Minimum inhibitory concentration (MIC) values of all isolates were determined by E-test m...
Autores principales: | Kanchanasurakit, Sukrit, Srisawat, Chansinee, McPherson, Charles E, Saelim, Weerayuth, Siriplabpla, Wuttikorn, Suthumpoung, Pornsinee, Santimaleeworagun, Wichai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752188/ http://dx.doi.org/10.1093/ofid/ofac492.495 |
Ejemplares similares
-
Fosfomycin Dosing Regimens based on Monte Carlo Simulation for Treated Carbapenem-Resistant Enterobacteriaceae Infection
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2020) -
Effectiveness of thiamine therapy in mortality rate in patients with septic shock: A systematic review and meta-analysis
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2021) -
Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
por: Saelim, Weerayuth, et al.
Publicado: (2021) -
Acetaminophen use and risk of renal impairment: A systematic review and meta-analysis
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2020) -
Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
por: Leelasupasri, Sombat, et al.
Publicado: (2018)